Computational re-design of protein structures to improve solubility

Area of Science:

• Biopharmaceutical Development
• Protein Therapeutics
• Drug Safety

Background:

• Protein therapeutics offer life-saving treatments but face limitations due to degradation, primarily protein aggregation.
• Protein aggregation impacts all stages of biopharmaceutical development and raises significant regulatory concerns regarding drug product safety.

Purpose of the Study:

• To review existing protein aggregation prediction methods.
• To focus on four recent 3D structure-based algorithms (SAP, CamSol, Solubis, Aggrescan3D) for predicting and improving protein solubility.
• To demonstrate the utility of these methods in designing proteins with enhanced solubility.

Main Methods:

• Review of protein aggregation prediction approaches.
• Focus on structure-based in silico algorithms utilizing 3D protein coordinates.
• Application of algorithms (SAP, CamSol, Solubis, Aggrescan3D) to predict aggregation propensity and protein solubility.

Main Results:

• Structure-based in silico methods accurately predict protein aggregation propensities.
• These computational tools can guide the selection of protein candidates with improved solubility.
• Examples illustrate the successful application of these algorithms in protein design.

Conclusions:

• In silico structure-based methods offer a powerful alternative to traditional, time-consuming wet lab experiments for assessing protein aggregation.
• These predictive tools can accelerate the development of therapeutic proteins, reduce industrial costs, and improve the safety profile of drug products.